Skip to main content

HS Disease

DRUGS IN THE PIPELINE FOR 

HIDRADENITIS SUPPURATIVA

 

Drugs in the pipeline for hidradenitis suppurativa are being developed and tested, but haven’t been approved by the U.S. Food and Drug Administration (FDA).  Drugs must be tested in three phases of clinical trials before the FDA decides whether to approve them.

We will report drugs being developed for hidradenitis suppurativa, learn about the differences between clinical trial phases, and see available clinical trial results.

Our Impact This Year

  • People Helped

    1497

  • Volunteer Hours

    2412

  • HS Speaks

    4

© 2024 ‎International Association of Hidradenitis Suppurativa Network

Powered by Firespring